Acute Musculoskeletal Pain or Arthralgia in Sjögren Syndrome

Patients with Sjögren syndrome may present with acute musculoskeletal pain or arthralgia as part of their clinical course. Addressing this presentation with an evidence-based approach — while accounting for the underlying condition — is the focus of this protocol.

This protocol covers the management of acute musculoskeletal pain or arthralgia occurring in the setting of confirmed Sjögren syndrome. Symptomatic relief is the primary immediate goal, with careful attention to safety considerations relevant to this patient population.

Treatment Approach

The recommended approach involves analgesic and anti-inflammatory agents for symptomatic relief, with specific guidance on duration of use and the choice between systemic and topical options. The full protocol details the selection criteria, sequencing, and safety considerations — including side effects and comorbid disease factors.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/annrheumdis-2019-216114

In patients presenting with acute musculoskeletal pain, consider acetaminophen or NSAIDs for symptomatic relief, always for less than 7-10 consecutive days at full dosage and considering the side effects and underlying comorbid diseases.

Topical formulations of NSAIDs (topical diclofenac or ketoprofen) may be effective for local pain with fewer side effects.

View source ↗